ABOUT THIS EVENT

Harmony Biosciences (“Harmony”), (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients living with rare neurological disorders who have unmet medical needs, rang the Nasdaq Closing Bell remotely from across the country.

In celebration of its IPO, John C. Jacobs, MBA, President & CEO, rang the Closing Bell in a virtual bell ringing ceremony.